Dopamine-induced functional activation of Gαq mediated by dopamine D1-like receptor in rat cerebral cortical membranes

被引:7
作者
Odagaki, Yuji [1 ]
Kinoshita, Masakazu [1 ]
Ota, Toshio [1 ]
机构
[1] Saitama Med Univ, Fac Med, Dept Psychiat, Saitama, Japan
关键词
G protein; dopamine; dopamine D-1-like receptor; 5-HT2A receptor; pergolide; GAMMA-S BINDING; SCINTILLATION PROXIMITY; SEROTONIN; BRAIN; SCH-23390; PROTEINS; ANTAGONIST; AGONISM; 5-HT2; SELECTIVITY;
D O I
10.1080/10799893.2018.1562470
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although multiple roles of dopamine through D-1-like (D-1 and D-5) and D-2-like (D-2, D-3, and D-4) receptors are initiated primarily through stimulation or inhibition of adenylyl cyclase via G(s/olf) or G(i/o), respectively, there have been many reports indicating diverse signaling mechanisms that involve alternative G protein coupling. In this study, dopamine-induced G alpha(q) activation in rat brain membranes was investigated. Agonist-induced G alpha(q) activation was assessed by increase in guanosine-5 '-O-(3-[S-35]thio)triphosphate ([S-35]GTP gamma S) binding to G alpha(q) determined by [S-35]GTP gamma S binding/immunoprecipitation assay in rat brain membranes. Dopamine-stimulated G alpha(q) functionality was highest in cortex as compared to hippocampus or striatum. In cerebral cortical membranes, this effect was mimicked by benzazepine derivatives with agonist properties at dopamine D-1-like receptors, that is, SKF83959, SKF83822, R(+)-SKF81297, R(+)-SKF38393, and SKF82958, but not by the compounds with dopamine D-2-like receptor agonist properties except for aripiprazole. Against expectation, stimulatory effects were also induced by SKF83566, R(+)-SCH23390, and pergolide. The pharmacological profiling by using a series of antagonists indicated that dopamine-induced response was mediated through dopamine D-1-like receptor, which was distinct from the receptor involved in 5-HT-induced response (5-HT2A receptor). Conversely, the responses induced by SKF83566, R(+)-SCH23390, and pergolide were most likely mediated by 5-HT2A receptor, but not by dopamine D-1-like receptor. Caution should be paid when interpreting the experimental data, especially in behavioral pharmacological research, in which SKF83566 or R(+)-SCH23390 is used as a standard selective dopamine D-1-like receptor antagonist. Also, possible clinical implications of the agonistic effects of pergolide on 5-HT2A receptor has been mentioned.
引用
收藏
页码:9 / 17
页数:9
相关论文
共 54 条
  • [1] The Physiology, Signaling, and Pharmacology of Dopamine Receptors
    Beaulieu, Jean-Martin
    Gainetdinov, Raul R.
    [J]. PHARMACOLOGICAL REVIEWS, 2011, 63 (01) : 182 - 217
  • [2] Activation, internalization, and recycling of the serotonin 2A receptor by dopamine
    Bhattacharyya, Samarjit
    Raote, Ishier
    Bhattacharya, Aditi
    Miledi, Ricardo
    Panicker, Mitradas M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (41) : 15248 - 15253
  • [3] Drug-induced fibrotic valvular heart disease
    Bhattacharyya, Sanjeev
    Schapira, Anthony H.
    Mikhailidis, Dimitri P.
    Davar, Joseph
    [J]. LANCET, 2009, 374 (9689) : 577 - 585
  • [4] THE D-1 DOPAMINE RECEPTOR ANTAGONIST SCH 23390 ALSO INTERACTS POTENTLY WITH BRAIN-SEROTONIN (5-HT2) RECEPTORS
    BISCHOFF, S
    HEINRICH, M
    SONNTAG, JM
    KRAUSS, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 129 (03) : 367 - 370
  • [5] Bourne JA, 2001, CNS DRUG REV, V7, P399
  • [6] ACTIVATION OF THE 5-HT1C RECEPTOR EXPRESSED IN XENOPUS OOCYTES BY THE BENZAZEPINES SCH-23390 AND SKF-38393
    BRIGGS, CA
    POLLOCK, NJ
    FRAIL, DE
    PAXSON, CL
    RAKOWSKI, RF
    KANG, CH
    KEBABIAN, JW
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (04) : 1038 - 1044
  • [7] KETANSERIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN HYPERTENSION AND PERIPHERAL VASCULAR-DISEASE
    BROGDEN, RN
    SORKIN, EM
    [J]. DRUGS, 1990, 40 (06) : 903 - 949
  • [8] D1-D2 Dopamine Receptor Synergy Promotes Calcium Signaling via Multiple Mechanisms
    Chun, Lani S.
    Free, R. Benjamin
    Doyle, Trevor B.
    Huang, Xi-Ping
    Rankin, Michele L.
    Sibley, David R.
    [J]. MOLECULAR PHARMACOLOGY, 2013, 84 (02) : 190 - 200
  • [9] Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study
    Ecker, Daniel
    Unrath, Alexander
    Kassubek, Jan
    Sabolek, Michael
    [J]. BMC NEUROLOGY, 2009, 9
  • [10] Evidence against dopamine D1/D2 receptor heteromers
    Frederick, A. L.
    Yano, H.
    Trifilieff, P.
    Vishwasrao, H. D.
    Biezonski, D.
    Meszaros, J.
    Urizar, E.
    Sibley, D. R.
    Kellendonk, C.
    Sonntag, K. C.
    Graham, D. L.
    Colbran, R. J.
    Stanwood, G. D.
    Javitch, J. A.
    [J]. MOLECULAR PSYCHIATRY, 2015, 20 (11) : 1373 - 1385